Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Lateral Epicondylitis, Unspecified Elbow: early-phase trial registry

1 of 2 indexed Lateral Epicondylitis, Unspecified Elbow trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Lateral Epicondylitis, Unspecified Elbow: 2 US clinical trials tracked, 1 recruiting.

Lateral Epicondylitis, Unspecified Elbow is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Siddharth Padia, MD, running 1 of these trials.

Enrollment posture brief

Registry condition lateral-epicondylitis-unspecified-elbow

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Lateral Epicondylitis, U (th…50%
Open-enrollment share among volume-matched conditions near Lateral Epicondylitis, Unspecified Elbow

Lateral Epicondylitis, Unspecified Elbow lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Lateral Epicondylitis, Unspecified Elbow on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Lateral Epicondylitis, Unspecified Elbow is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Lateral Epicondylitis, Unspecified Elbow records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Doxycycline Hyclate 20 MG Drug
1 trials
Embozene particles Device
1 trials

US sites by state

Facility locations filed on Lateral Epicondylitis, Unspecified Elbow trials. A trial with sites in several states counts in each.

New York 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Lateral Epicondylitis, Unspecified Elbow page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Lateral Epicondylitis, Unspecified Elbow trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Siddharth Padia, MD sponsors the most Lateral Epicondylitis, Unspecified Elbow trials on record, review their full trial history before evaluating a specific study. See Siddharth Padia, MD's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lateral Epicondylitis, Unspecified Elbow condition card totals 2 registered trials; most-linked intervention Doxycycline Hyclate 20 MG; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.